Sify.com » Topics » Amylin
Amylin News
EU suggests new approval for diabetes drug Byetta
Amylin Pharmaceuticals Inc. and Eli Lilly and Co. said Friday that a panel advising the European Medicines Agency recommended a new approval for their diabetes drug Byetta.The advisory panel recommended that Byetta be approved for use in combination with basal insulin with or without other common diabetes treatments in patients who have not been able to get their blood sugar under control with the
Amylin Pharmaceuticals Inc. and Eli Lilly and Co. said Friday that a panel advising the European Medicines Agency recommended a new approval for their diabetes drug Byetta.The advisory panel recommended that Byetta be approved for use in combination with basal insulin with or without other common diabetes treatments in patients who have not been able to get their blood sugar under control with the
BofA, Delta, Thomas & Betts are market movers
Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and Nasdaq Stock Market:
Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and Nasdaq Stock Market:
Summary Box: Lilly receives restraining order
: Amylin Pharmaceuticals Inc. said Thursday a federal court issued an injunction preventing drug development partner Eli Lilly and Co. from using the same sales force to sell an Amylin-developed
Court issues restraining order against Eli Lilly
Amylin Pharmaceuticals Inc. said Thursday a federal court issued an injunction preventing drug development partner Eli Lilly and Co. from using the same sales force to sell an Amylin-developed
Amylin 1Q loss narrows on lower costs
Amylin Pharmaceuticals reported that its first-quarter loss narrowed as it spent less on both its sales force and on research and development.
Amylin Pharmaceuticals reported that its first-quarter loss narrowed as it spent less on both its sales force and on research and development.
Clarification: Amylin FDA info request story
In a story March 15, The Associated Press reported that Bydureon is the proposed trade name of exenatide, a diabetes treatment being developed by Amylin Pharmaceuticals Inc., Eli Lilly&Co. and
© Copyright Sify Technologies Ltd, 1998-2011. All rights reserved. India News Portal, Sify.com hosted at SifyHosting India's first Level 3 Internet Data Centre.
Site optimized for Internet Explorer 5.5 and above.
See Disclaimer |Privacy Policy &Parental Guidance on pornography |careers@sify |About Us |Feedback |Advertise
Site optimized for Internet Explorer 5.5 and above.
See Disclaimer |Privacy Policy &Parental Guidance on pornography |careers@sify |About Us |Feedback |Advertise